Developing Therapeutics for Alzheimer's Disease: Progress and Challenges. 1st ed

Published by: Elsevier Inc.  

People

  1. Li
    Li

Groups

  1. GSK Faculty (1)
  2. Molecular Pharmacology and Chemistry Program Faculty (1)
  3. Population Sciences Research Program (1)
  4. Sloan Kettering Institute Faculty (1)
  5. Sloan Kettering Institute Postdocs (1)
Search Within
  1. "2016"
Formats
  1. Book Section (1)
Groups
  1. GSK Faculty (1)
  2. Molecular Pharmacology and Chemistry Program Faculty (1)
  3. Population Sciences Research Program (1)
  4. Sloan Kettering Institute Faculty (1)
  5. Sloan Kettering Institute Postdocs (1)
People
  1. Ji Yeun Hur (1)
  2. Natalya Gestsik (1)
  3. Yueming Li (1)
Years
  1. 2016 (1)
Publishers
  1. Elsevier Inc. (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • γ-secretase inhibitors: From chemical probes to drug development
    Book Section

    Hur, J. Y.; Gertsik, N.; Johnson, D. S.; Li, Y. M.
    In Wolfe, M. S. (Eds.) Developing Therapeutics for Alzheimer's Disease: Progress and Challenges. 1st ed (2016)

    Fulltext@MSK | Save

    • Developing Therapeutics for Alzheimer's Disease: Progress and Challenges. 1st ed – authorized name for:

    Name ISSN / ISBN Publisher
    Developing Therapeutics for Alzheimer's Disease: Progress and Challenges 978-0-12-802173-6 Elsevier Inc.
    Developing Therapeutics for Alzheimer's Disease: Progress and Challenges. 1st ed 978-0-12-802173-6 Elsevier Inc.